ALKERMES, INC.

Medicare/Medicaid

Patient access and maintain six protected classes for depressions and schizophrenia under Medicare Part D; Ensure patient access to behavioral health services and treatments through telehealth; Inflation Reduction Act of 2022 implementation;

TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)

Health Issues

Awareness of the need for treatment system reform and access to all FDA-approved medications; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments; Awareness of outcomes data and the need for training on all medication assisted treatment; Ensure patient access to appropriate medications by limiting the unnecessary use of utilization management policies, including H.R. 2163/S. 464 the Safe Step Act; Policies impacting pharmaceutical development, reimbursement, and patient access and cost; Awareness of need for transparency and patient access within the 340B program; FY2024 - Labor, Health and Human Services, Education Appropriations; FY2024 - Commerce, Justice, Science, and Related Agencies Appropriations; FY2024 - Military Construction, Veterans Affairs, and Related Agencies Appropriations;

TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Office of Natl Drug Control Policy (NDCP) · Health & Human Services, Dept of (HHS) · Natl Institutes of Health (NIH) · Substance Abuse & Mental Health Services Administration (SAMHSA)